Therapeutic targeting of MALT1 in oncology: Mechanism, inhibitor development, and clinical prospects

Documenti analoghi

• Pan‐cancer analysis and oncogenic implications of MGAM and MGAM2: Toward precision oncology and drug repurposing in colorectal cancer
  di: Rawaa Chasib Mezher, et al.
  Pubblicazione: (2025)
• Overexpressed miR‐486 in bone marrow mesenchymal stem cells represses urethral fibrosis and targets Col13a1 in urethral stricture rats
  di: Yali Xu, et al.
  Pubblicazione: (2024)
• A comprehensive analysis of the relationship between inflammasomes and autophagy in human tumors: Recent developments
  di: Sai Liu, et al.
  Pubblicazione: (2025)
• Naa10p impairs PGC‐1α/Pparγ2 interaction to inhibit mitochondrial protection in pancreatitis
  di: Jie Du, et al.
  Pubblicazione: (2025)
• CD99 contributes to the EWS::FLI1 transcriptome by specifically affecting FOXM1‐targets involved in the G2/M cell cycle phase, thus influencing the Ewing sarcoma genetic landscape
  di: Michela Pasello, et al.
  Pubblicazione: (2024)